The Lung Cancer Research Foundation has issued an RFP for the LCRF Pilot Grant Program.
The foundation invites proposals for innovative projects across the full spectrum of basic, translational, clinical, epidemiological, health services, and other research focused on one or more of the following topics: lung cancer biology; prevention and screening for early detection; identification of new biomarkers; development of more effective and less toxic therapies, including but not limited to targeted and immune-therapies; mechanisms of sensitivity and resistance to lung cancer therapies; supportive measures for people with lung cancer and their families; and quality of care and outcomes research.
Grants of up to $150,000 over two years will be awarded to support early- and mid-career investigators.
Eligible applicants include those from U.S.-based and international institutions, and applicants may hold any residency/citizenship status. Investigators must be affiliated with a nonprofit academic or research institution and must be a postdoctoral researcher, clinical fellow, or early-career or mid-career investigator with less than ten years’ experience since their initial faculty appointment.
Letters of Intent are due April 30. Upon review, selected applicants will be invited to submit a full proposal by August 27, 2021.
See the Lung Cancer Research Foundation website for complete program guidelines and application instructions.